Treatment of hypercholesterolaemia with PCSK-9 Inhibitors in Denmark. Assessment of real-life data; safety an extent of adverse effects after the first years of clinical use

S. Mulverstedt; I. C. Klausen; M. H. Martinsen; H. Kanstrup; K. K. Thomsen; J. Knold; F. L. Henriksen; L. J. Andersen; E. B. Schmidt; J. Theilade; J. Clausen; K. M. Yafasov; K. Egstrup; J. S. Jensen; M. Heitmann

doi:10.1093/eurheartj/ehz747.0311

Treatment of hypercholesterolaemia with PCSK-9 Inhibitors in Denmark. Assessment of real-life data; safety an extent of adverse effects after the first years of clinical use

S. Mulverstedt
, I. C. Klausen
, M. H. Martinsen
, H. Kanstrup
, K. K. Thomsen
, J. Knold
, F. L. Henriksen
, L. J. Andersen
, E. B. Schmidt
, J. Theilade
, J. Clausen
, K. M. Yafasov
, K. Egstrup
, J. S. Jensen
, M. Heitmann

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Artikelnummer	P706
Tidsskrift	European Heart Journal
Vol/bind	40
Udgave nummer	Suppl. 1
Sider (fra-til)	313
Antal sider	1
ISSN	0195-668X
DOI	https://doi.org/10.1093/eurheartj/ehz747.0311
Status	Udgivet - okt. 2019
Begivenhed	Congress of the European Society of Cardiology (ESC)/World Congress of Cardiology - Paris, Frankrig Varighed: 31. aug. 2019 → 4. sep. 2019

Konference

Konference	Congress of the European Society of Cardiology (ESC)/World Congress of Cardiology
Land/Område	Frankrig
By	Paris
Periode	31/08/2019 → 04/09/2019

Dokumenter og links

10.1093/eurheartj/ehz747.0311

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Mulverstedt, S., Klausen, I. C., Martinsen, M. H., Kanstrup, H., Thomsen, K. K., Knold, J., Henriksen, F. L., Andersen, L. J., Schmidt, E. B., Theilade, J., Clausen, J., Yafasov, K. M., Egstrup, K., Jensen, J. S., & Heitmann, M. (2019). Treatment of hypercholesterolaemia with PCSK-9 Inhibitors in Denmark. Assessment of real-life data; safety an extent of adverse effects after the first years of clinical use. European Heart Journal, 40(Suppl. 1), 313. Artikel P706. https://doi.org/10.1093/eurheartj/ehz747.0311

@article{0d98f05cb2ba440cbb3bb01981caf71e,

title = "Treatment of hypercholesterolaemia with PCSK-9 Inhibitors in Denmark. Assessment of real-life data; safety an extent of adverse effects after the first years of clinical use",

author = "S. Mulverstedt and Klausen, \{I. C.\} and Martinsen, \{M. H.\} and H. Kanstrup and Thomsen, \{K. K.\} and J. Knold and Henriksen, \{F. L.\} and Andersen, \{L. J.\} and Schmidt, \{E. B.\} and J. Theilade and J. Clausen and Yafasov, \{K. M.\} and K. Egstrup and Jensen, \{J. S.\} and M. Heitmann",

year = "2019",

month = oct,

doi = "10.1093/eurheartj/ehz747.0311",

language = "English",

volume = "40",

pages = "313",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "Suppl. 1",

note = "Congress of the European Society of Cardiology (ESC)/World Congress of Cardiology ; Conference date: 31-08-2019 Through 04-09-2019",

}

Mulverstedt, S, Klausen, IC, Martinsen, MH, Kanstrup, H, Thomsen, KK , Knold, J , Henriksen, FL, Andersen, LJ, Schmidt, EB, Theilade, J, Clausen, J, Yafasov, KM, Egstrup, K, Jensen, JS & Heitmann, M 2019, 'Treatment of hypercholesterolaemia with PCSK-9 Inhibitors in Denmark. Assessment of real-life data; safety an extent of adverse effects after the first years of clinical use', European Heart Journal, bind 40, nr. Suppl. 1, P706, s. 313. https://doi.org/10.1093/eurheartj/ehz747.0311

Treatment of hypercholesterolaemia with PCSK-9 Inhibitors in Denmark. Assessment of real-life data; safety an extent of adverse effects after the first years of clinical use. / Mulverstedt, S.; Klausen, I. C.; Martinsen, M. H. et al.
I: European Heart Journal, Bind 40, Nr. Suppl. 1, P706, 10.2019, s. 313.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Treatment of hypercholesterolaemia with PCSK-9 Inhibitors in Denmark. Assessment of real-life data; safety an extent of adverse effects after the first years of clinical use

AU - Mulverstedt, S.

AU - Klausen, I. C.

AU - Martinsen, M. H.

AU - Kanstrup, H.

AU - Thomsen, K. K.

AU - Knold, J.

AU - Henriksen, F. L.

AU - Andersen, L. J.

AU - Schmidt, E. B.

AU - Theilade, J.

AU - Clausen, J.

AU - Yafasov, K. M.

AU - Egstrup, K.

AU - Jensen, J. S.

AU - Heitmann, M.

PY - 2019/10

Y1 - 2019/10

U2 - 10.1093/eurheartj/ehz747.0311

DO - 10.1093/eurheartj/ehz747.0311

M3 - Conference abstract in journal

SN - 0195-668X

VL - 40

SP - 313

JO - European Heart Journal

JF - European Heart Journal

IS - Suppl. 1

M1 - P706

T2 - Congress of the European Society of Cardiology (ESC)/World Congress of Cardiology

Y2 - 31 August 2019 through 4 September 2019

ER -